Edition:
United Kingdom

Coherus BioSciences Inc (CHRS.OQ)

CHRS.OQ on NASDAQ Stock Exchange Global Market

12.33USD
19 Oct 2018
Change (% chg)

$-0.38 (-2.99%)
Prev Close
$12.71
Open
$12.71
Day's High
$12.91
Day's Low
$12.06
Volume
166,344
Avg. Vol
164,067
52-wk High
$20.65
52-wk Low
$8.07

Chart for

About

Coherus BioSciences, Inc. is a late-stage clinical biologics platform company. The Company is engaged in the business of developing and commercializing biosimilar products. The Company's business is organized around therapeutic franchises, including Oncology biosimilar candidates pegfilgrastim (Neulasta) and bevacizumab... (more)

Overall

Beta: --
Market Cap(Mil.): $695.75
Shares Outstanding(Mil.): 51.35
Dividend: --
Yield (%): --

Financials

  CHRS.OQ Industry Sector
P/E (TTM): -- 85.68 33.65
EPS (TTM): -2.70 -- --
ROI: -86.92 0.45 14.28
ROE: -- 1.37 16.00

BRIEF-Coherus Prices Public Offering Of Common Stock

* SAYS PUBLIC OFFERING OF 5.17 MILLION COMMON SHARES PRICED AT $14.50PER SHARE Source text for Eikon: Further company coverage:

23 May 2018

BRIEF-Coherus Announces Proposed Public Offering Of Common Stock

* COHERUS BIOSCIENCES INC SAYS COMMENCED UNDERWRITTEN PUBLIC OFFERING OF $75,000,000 OF SHARES OF ITS COMMON STOCK Source text for Eikon: Further company coverage:

21 May 2018

BRIEF-Coherus BioSciences Re-Submits Biologics License Application For CHS-1701

* COHERUS BIOSCIENCES RE-SUBMITS BIOLOGICS LICENSE APPLICATION FOR CHS-1701 (PEGFILGRASTIM BIOSIMILAR CANDIDATE)

03 May 2018

Competitors

  Price Chg
Amgen, Inc. (AMGN.OQ) $201.80 -0.92
Pfizer Inc. (PFE.N) $44.50 +0.50
Mylan NV (MYL.OQ) $32.21 -0.21
Teva Pharmaceutical Industries Limited (TEVA.TA) 7,940.00 +251.00
LG Chem Ltd (051910.KS) ₩330,000.00 +13,000.00
LG Chem Ltd (051915.KS) ₩190,500.00 +9,500.00
AbbVie Inc (ABBV.N) $87.97 -1.93
Momenta Pharmaceuticals, Inc. (MNTA.OQ) $13.65 -1.09
FUJIFILM Holdings Corp (4901.T) ¥4,948 -30.00

Earnings vs. Estimates